MetaData Asset Management Facilitates Strategic OCT Patent Ecosystem License Agreement Between Sightline Innovation (SII) and AnoSense Solutions (ANO)
ANO to Integrate SII's Optical Coherence Tomography (OCT) IP into Personal-Device Dermatology Clinic Intake System, Streamlining Longitudinal Imagery Access, Increasing Clinic Productivity, and Addressing Basal Cell Carcinoma (BCC) Surveillance Across Canada
MDAM-facilitated inter-ecosystem license from Sightline Innovation (SII) to AnoSense Solutions (ANO)
Subsurface & morphological lesion delta imagery built into personal-device (iOS/Android) intake scanning
Streamlined longitudinal healthcare & imagery data enables dermatology clinics to service more customers
Addresses the largest oncological monitoring need in the Canadian population—skin cancer (BCC) across time
MetaData Asset Management (MDAM) has facilitated a strategic license agreement between Sightline Innovation Inc. (SII) and AnoSense Solutions Inc. (ANO) for SII's Optical Coherence Tomography (OCT) ecosystem of patents. ANO is deploying this IP to build tomographic change detection imagery directly into its dermatology clinic intake system—leveraging personal device change detection scanning for skin lesions to streamline longitudinal healthcare and imagery data access, boost dermatology clinic productivity to service more customers, and address the largest oncological monitoring need in the Canadian population: surveilling for skin cancer such as Basal Cell Carcinoma (BCC) across time.
TORONTO & OTTAWA, ON — October 19, 2026 — MetaData Asset Management (MDAM), a high-conviction deep-tech venture studio and sovereign intellectual property ecosystem hub, today announced that it has facilitated a strategic intellectual property license agreement between ecosystem companies Sightline Innovation Inc. (SII) and AnoSense Solutions Inc. (ANO) covering SII's foundational Optical Coherence Tomography (OCT) ecosystem of patents.
Under the terms of the MDAM-facilitated agreement, AnoSense Solutions (ANO) will utilize SII's OCT patent ecosystem to build advanced tomographic change detection imagery directly into its dermatology clinic intake system. By combining SII's patented tomographic reconstruction and optical interferometry algorithms with ANO's personal-device change detection scanning for skin lesions on standard iPhone and Android smartphones, the platform captures both surface morphology and subsurface structural evolution across sequential patient scans.
This integration provides partner dermatology clinics with streamlined, pre-triaged access to longitudinal healthcare records and high-resolution tomographic change detection imagery data prior to in-person consultations. Equipped with quantified temporal delta vectors—measuring micro-millimeter lesion boundary velocity, nodular elevation shifts, and subsurface vascular remodeling—dermatology clinics can eliminate manual intake bottlenecks, operate at a significantly higher productivity level, and service more customers with greater diagnostic precision.
Critically, the combined SII × ANO capability directly addresses the largest oncological monitoring need in the Canadian population: continuous, multi-year surveillance for skin cancer—such as Basal Cell Carcinoma (BCC)—across time. With non-melanoma skin cancers led by BCC representing the highest-incidence malignancy in Canada and placing immense strain on specialist waitlists, empowering patients to perform longitudinal personal-device lesion scanning linked directly to clinical tomographic intake enables earlier intervention, higher clinic throughput, and nationwide oncological continuity of care.
All longitudinal healthcare and tomographic imagery datasets are cryptographically attested at the mobile edge and transmitted via the open-source ZeroServer Mesh (BVS1 sovereign storage and Kuma mutual-TLS service mesh) under strict patient-consented HIPAA and Canadian PIPEDA zero-trust access controls.
"By bridging Sightline Innovation's Optical Coherence Tomography patent ecosystem with AnoSense's personal-device dermatology intake network, MetaData Asset Management is demonstrating the compounding power of our venture studio ecosystem—arming Canadian dermatology clinics with longitudinal tomographic change detection imagery so clinicians can operate at peak productivity and meet Canada's largest oncological surveillance challenge in Basal Cell Carcinoma head-on."
🔬How SII OCT Patents Power ANO's Dermatology Clinic Intake System
End-to-end longitudinal skin lesion change detection & Basal Cell Carcinoma (BCC) surveillance pipeline
📱Personal-Device Lesion Scanning (iPhone & Android)
Patients capture guided multi-angle skin lesion scans on standard iPhone and Android smartphones with automated optical distance calibration and Ed25519 device attestation.
🔬SII OCT Patent Ecosystem Tomographic Reconstruction
Licensed Sightline Innovation (SII) Optical Coherence Tomography (OCT) interferometry and neural reconstruction algorithms synthesize subsurface & morphological change detection imagery.
📊Streamlined Longitudinal Healthcare & Imagery Data
Sequential scans are spatially integrated onto a 3D anatomical mesh, quantifying lesion boundary velocity, nodular elevation shifts, and vascular remodeling across time in BVS1 sovereign storage.
🩺High-Productivity Canadian Clinic Intake & BCC Surveillance
Dermatology clinics receive pre-triaged longitudinal healthcare and tomographic imagery packets—operating at higher productivity, servicing more customers, and surveilling for Basal Cell Carcinoma (BCC) across time.